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I N THE EARLIER DAYS of renal homotrans- plantation, the most important cause 
of failure was prompt rejection of the 
homograft. Except for a few tantalizing 
exceptions, most of the patients treated by 
this means died during the first few weeks 
after operation either from return of renal 
failure or as the result of drug toxicity 
induced during efforts to prevent repudia- 
tion of the homograft. Such tragically 
unsuccessful cases of the pioneering era 
constituted the largest portion of the com- 
pilation of world experience made in Sep- 
tember, 1963, by Murray (1) and the other 
participants at the National Academy of 
Sciences transplantation conference in 
Washington, D. C .  
From our own experience (2, 3) and 
from that of other investigators (4-8), a 
quite different view has emerged during 
the last 2 years concerning the potentiali- 
ties of renal homotransplantation. Al- 
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though rejection or drug toxicity, or both, 
are still important causes of acute post- 
operative mortality, three fourths of all 
patients treated at the University of Color- 
ado Medical Center with homografts ob- 
tained from living donors have survived 
for longer than 2 months and considerably 
more than half are still alive on June 10, 
1964, from 24 to 18 months postoperative. 
It has been learned that rejection, when 
it occurs, can be reversed, even when it is 
of great severity (2, 5, 7-11), that the de- 
gree of requisite immunosuppressive ther- 
apy usually diminishes late in the post- 
operative period, and that the successfully 
treated patients can resume life in a rela- 
tively unrestricted environment. Imperfect 
though they are, the techniques of surgery 
and early postoperative care, as they are 
practiced today, provide the recipient with 
a greatly improved outlook. With favorable 
combinations of consanguinity, such as 
those obtained with the use of sibling or 
parental donors, the prospects of surviv- 
ing into a chronic stage approach accepta- 
bility (2-5). 
In spite of these encouraging notes, the 
long-term value of renal homotransplanta- 
tion in the treatment of terminal diseases 
of the kidney remains conjectural. Little is 
known of the projected fate of the homo- 
grafts or of their recipients sincc only a 
handful of late cases have been reported. 
This paper analyzes a large group of pa- 
tients who lived for more than 4 months 
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after  operation a n d  attempts to character- 
ize those late problems that  have already 
been encountered a n d  that  may become 
increasingly prominent with the further 
passage of time. Special attention will be 
focused upon the  adequacy of late homo- 
graft function; the  frequency, severity, di- 
agnosis, a n d  therapy of delayed rejection; 
the  incidence a n d  treatment of indolent 
mechanical urologic complications; t he  
long-term side effects of d r u g  administra- 
tion; and the  possible role of thymectomy 
in favorably influencing the  chronic course. 
CASE MATERIAL 
Fifty-one persons were treated 4 months 
or longer ago (Table 1). The operations 
took place in the  interval between Novem- 
ber 24, 1962, a n d  February 10, 1964. 
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in doses of 100 to 200 mg/day of prednisone 
and continuing into the postoperative period 
(Figure 2). If rejection occurred with this 
regimen, it was treated with intravenous actino- 
mycin C or local transplant irradiation, or 
both (Figure 2). Withdrawal of the steroids 
was carried out at  approximately the same rate 
as in the other groupand for this reason, both 
the early and later cases will be grouped to- 
gether for purposes of subsequent discussion. 
All 51 patients had splenectomy, usually at  
the same-time as bilateral nephrectomy -and 
renal homotransplantation, but occasionally in 
advance of the definitive operation. Justifica- 
tion for the use of this adjuvant procedure has 
been presented previousl< although direct ex- 
perimental evidence supporting its use has not 
been demonstrated either in our laboratories 
or elsewhere (2, 15). Eight of the first patients 
also had thymectomy from 13 to 85 days before 
transplantation (Table 1). The rationale for 
use of this operation is discussed in more de- 
tail below, since it is possible that some delayed 
benefit may accrued from its use. 
Eighteen patients died in the first 4 months. 
Their courses, factors contributing to early PROVISIONS FOR CHRONIC CARE 
success, a n d  the  causes for failure are de- If late complications are to be effectively 
treated, it is essential that they be diagnosed 
scribed (29 3, and be promptly. For this reason all patients are fol- 
considered here. T h e  genetic relationships lowed in two special transplantation clinics 
of the donors for the entire group of 51 
cases are  indicated in T a b l e  1, a n d  i t  will 
be noted that  the preponderance of good 
results occurred when the donors a n d  re- 
cipients were closely related. Thirty-three 
of the 51 patients lived for a t  least 4 
months, and  this residual group of longer 
survivors forms the basis for  this report. 
IMMUNOSUPPRESSIVE MEASURES 
I n  44 of the cases, initial therapy was pro- 
vided with a single drug, azathioprine, started 
before operation and continued indefinitely. 
At the time of rejection, massive doses of pred- 
nisone (as much as 300 mg/day) were added 
(Figure 1). In  many cases actinomycin C (12) 
and local irradiation to the transplant site (11, 
IS, 14) were intermittently used (2, 3). After 
reversal of rejection, the prednisone was re- 
duced as promptly as possible to maintenance 
levels of 40 to 60 mg/day and slower steroid 
withdrawal was then attempted in the ensuing 
weeks and months (Figure 1). 
I n  seven cases, steroids were used prophylac- 
tically, beginning 1 to 3 days before operation 
after discharge from the hospital. These clinics, 
which are staffed with internists, pediatricians, 
immunologists, and surgeons, have a relatively 
fixed personnel so that patients can be repeat- 
edly examined by the same physicians. A spe- 
cial effort is made to obtain accurate blood 
pressure measurements and weight and to thor- 
oughly evaluate as well any local features of 
the transplant site. Hematologic studies and 
creatinine clearance determinations are ver- 
formed by research laboratories so that greater 
dependence can be placed on small changes for 
the formulation of therapeutic policy. Ordi- 
narily, follow-up visits are scheduled once a 
week for the first month or two after discharge, 
but subsequently the patients may be seen only 
once every 2 to 8 weeks. At this phase of con- 
valescence they are often allowed to return 
to their homes. even if these are in distant 
cities, under the care of physicians who are 
carefully selected on the basis of their special 
interest in renal disease. Each patient is im- 
pressed with the necessity of immediately seek- 
ing medical care if fluid retention, oliguria, or 
transplant wound tenderness is noticed. Be- 
tween clinic visits, no restrictions are placed on 
activity except for avoidance of contact sports 
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TABLE 1. Clinical Data Concerning 
No. Patient's Date of Living Dnra- Age Rlood Donor Donor Ischemia 
Diagnosis* Operation or tion Sex Type Blood Relationship 
Dead of Type 
Snr- 
vival 
CGN 
CGN 
CGN 
CGN 
Polycystic 
CGN 
CGS 
Accidental 
Surgical 
Removal 
Only Kidney 
CGN 
CGN 
CPN 
CGN 
CGN 
CPN 
CGN 
Congital 
H ypoplasia 
CPN 
CGN 
CPV 
CGX 
CPX 
Polycystic 
Polsc~~st ic  
CGY, gouty 
nephritis 
CGK 
CGN 
CGV 
CGN 
CPN 
CGN 
CPN 
CGN 
CGN 
Living 
Living 
Living 
Dead 
Dead 
Living 
Dead 
Dead 
Dead 
Dead 
Dead 
Living 
Living 
Living 
Living 
Dead 
Living 
Living 
Dead 
Dead 
Dead 
Dead 
Living 
Removed 
3 hr 
Living 
Dead 
Living 
Dead 
Living 
Dead 
Removed 
3 days 
Dead 
Living 
Dead 
Dead 
Living 
days 
564 
496 
487 
113 
11 
419 
79 
62 
Mother 
Sister 
Fraternal 
Twin 
Unrelated 
F (wife) 
Unrelated M 
Brother 
Unrelated 
F (wife) 
Brother 
Fraternal 
Twin 
Unlelated M 
Brother 
Brother 
Mother 
Brother 
Brother 
Brother 
Mother 
Sister 
Mother 
Unrelated M 
Mother 
Unrelated 
F (wife) 
Mother 
Brother 
Unrelated M 
Unrelated M 
Brother 
Father 
Unrelated hl 
Sister 
Sister 
Unrelated M 
Unrelated M 
Unrelated M 
Brother 
Mother 
min 
34 
28  
24 
36 
71** 
35 
41 
(2 arteries) 
61 
(2 arteries) 
28 
38 
30 
40 
26 
28 
22 
23 
174 
22 
30 
26 
41 
41 
37 
58 
43 
23 
4 0  
23 
2 1 
34 
84 
(2 arteries) 
30 
30 
42 
33 
29 
* CGN = chronic glomen~lonephritis: CPN = chronic gyelonephritis. 
t Steroid pretreatment. 
$ Total body irradiation. 
25 mg/day of mecamylamine. 
250 mg/day of alpha-methyl DOPA. 
** 35-min cardiac arrest; ? arteries. 
oslnophilia and fever. 23 days. 
f ATN = acute tubular necrosis. 
-Survival given is after second transplant. 
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Patients in Living Donor (LD) Series 
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No. Own Thym- Onset Onset May, 1964 Antihypertensive Drogs 
Kidneys ectomy Early Late May. 1964 
Retained Days Rejection Rejection Creat- BUN BP Pred- -- 
Before inine nlsone Chloro- Hydral- Reser- 
Trans- Clear- thiazide azlne pine 
plant ance 
No 
Right 
No 
No 
Right & 
Left 
No 
No 
No 
days 
3 0  
14 
16 
13 
28 
26 
No 
No 
days 
14 
25 
None 
? 17 & 
? 42 
None diag 
nosed 
18 
19 
4 
5 , 3 4  & 7 1  
3 
1 
7 
13 
None 
Definitett 
7 t  
5 & 29 
42  
6 
Instant 
days 
None 
None 
None 
- 
- 
None 
- 
- 
- 
229 
- 
300 
240 
None 
None 
None 
None 
None 
- 
mg 
None 
None 
Nevet 
Used 
- 
- 
None 
- 
- 
- 
- 
- 
45 
40  
Never 
Used 
3 0  
- 
2.5 
3 0  
- 
g/day 
None 
None 
- 
- 
None 
- 
- 
- 
- 
- 
1.5 
1 .o 
None 
None 
- 
None 
1 .0 
- 
mg/day 
None 
None 
None 
- 
- 
None 
- 
- 
ma/day  
None 
Xone 
None 
- 
- 
None 
- 
- 
- 
- 
- 
- 
- 
Kone 
Kone 
- 
None 
None 
- 
- 
- 
- 
0.5 
0.5 &$ 
Kone 
- 
r\-one 7 
0.5 
- 
No No 9 -- -. - - - - - - 
No No 1 None - -. - - - - 
No KO 4 None - - - - - - - 
No No 24 244 85.7 24 104/60 25 None None None 
No No Instant - - - - - - - - 
- - 18 223 85 32 190/110 40  None hTone Sone  
NO NO 17 Kone 90.0 19 114/80 5 None None Kone 
No No None - - - -. - - - - 
No No 7 19 None 7 0  28 134/100 25 1.0 None 0.5 
No No 13 - - - - - - - - 
No No None - - - - - - - - 
recognized 
No No 2 - - - - - - - - 
30 No No 7 112 57.5 54 160/98 40  2.0 200 1.0 
31 No No 5 - - - - - - - - 
32 No No 11 - - - - - - - - 
3 3  No No 6 None 75.0 18 130/98 10 1.0 Xons Xone 
Volume 61 No. 3 
September '1964 RENAL HOMOTRANSPLANTATION 
No. Patient's Date of Living Dura- Age Blood Donor Donor Ischemia 
Diagnosis* Operation or tion Sex Type Blood Relationship 
Dead or Type 
Sur- 
vival 
CGN 
CGN 
CGN 
CGN 
CPN 
CGN 
CGN 
CGN 
CGN 
days 
Living 243 
Removed 
21 days 
Dead 9*w 
Living 240 
Living 236 
Dead 38 
Living 210 
Living 207 
Living 200 
Living 196 
min 
Mother 42 
Unrelated M 27 
Sister 28 
Unrelated 38 
F (wife) 
Mother 24 
Mother 30 
Mother 18 
Mother 27 
Mother 32 
Father 26 
43 CGN 121 3/63 Dead 38 25 M Of O f  Mother 46 
44 CCN 12/ 7/63 Living 186 48 M A+ O+ Sister 38 
45 CGN 12/10/63 Living 183 35 M A +  A +  Sister 28 
46t CGN 1/ 3/64 Dead 43 25 I; Of 0- Unrelated M 3 1 
(husband) 
47t CGN 1/ 4/64 Living 158 37 M A+ A +  Brother 28 
48t CGN 1/10/64 Living 152 34 M B +  B +  Sister 3 1 
49t CGN 1st Removed 32 M A+ A +  Sister 57 
1/15/64 7 days 
2nd Living 99 A +  Sister 38 
3/ 3/64 
50t CGS 1/25/64 Living 147 16 F A f  A +  Father 2 7 
5 l t  CGN 2/10/64 Living 121 18 M Of Of Maternal 25 
aunt 
such as football. They go to movies and other 
public gatherings. Virtually all those patients 
now living more than 4 months have returned 
to some kind of work or to school. 
At each visit, blood urea nitrogen, creatinine 
clearance, hematocrit reading, white blood 
count and differential, urinalysis, and urine 
cultures are ordered. Frequently, intravenous 
pyelograms are obtained early in the postopera- 
tive course, and these are always performed 
after 3 months. If there is any equivocation 
about the normality of the ureteropelvic sys- 
are also valuable in judging the rapidity of 
emptying. Using this method, good visualiza- 
tion of the collecting system can almost always 
be obtained and, in fact, cystoscopy and retro- 
grade pyelography have been necessary on only 
one occasion. 
In a number of cases, radioisotope renograms 
were obtained with the method of Winter (17), 
using sodium orthoiodohippurate-1131 (Hippu- 
ran-1133 ) (0.9 mc/kg). 
tem, an intensification excretory urogram is 
obtained with a modification of Wilson's tech- "ORTALITY AND 
nique (16).. A test dose of 50% sodium diatri- These data  are  presented i n  T a b l e  2. 
zoate (Hypaque@)* is given, followed by intra- 
venous administration of 30 ml of the contrast MORTALITY AFTER 4 MONTHS 
material. An additional dose of 90 ml is then 
~ h i ~ ~ ~ - ~ h ~ ~ ~  of the first 51 patients lived 
given by continuous infusion over a 30-min 
period, during which time X-ray exposures are longer than 4 months. Subsequently, three 
made, developed, and reviewed. Delayed films these 
Manufactured by Winthrop Laboratories, New In one case (LD 9) death occurred 207 
York 18. N. Y. days after a n  emergency opera t ioq for con- 
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Continued 
No. Own Thyme- Onset Onset May, 1964 Antihypertensive Drugs 
Kidneys ectomy Early Late May. 1964 
Retained Days Rejection Rejection Creat- RUN BP Pred- -- 
Before inine nisone Chloro- HyGral- Keser- 
Trans- Clear- thiazide azine pine 
plant ance 
days days days mg/100 ml mm Hg mg g/day mg/day mg/day 
34 No No 13 None 50.5 16 114/80 5 0.75 30 None 
35 No No 18 - - - - - - - 
36 No No 1 None 121 21 140/100 20 1.5 150 0.75 
No 1 1 0  
No 3 
No 12 
No 8 
No 1 6  
No 4 
? immediate 
No ? A T N e  
No 2 
No 43 
No 31 
None 
- 
None 
None 
None 
None 
- 
None 
None 
- 
25 2.0 
- - 
15 None 
30 1 
5 1 
20 1 
xone 
- 
None 
150 
40 
None 
- 
100 
None 
- 
1 .o 
- 
None 
0.5 
0.3 
None 
- 
None 
None 
- 
17t No No 3 None 113 27 126/102 25 1.5 Ron? 0.75 
14 
? 34 
48 t  No No ? 2 None SO 19 120/80 25 1 None Kone 
49t  No No Not clear - - - - - - - - 
None None 65 30 120/80 20 1 None None 
50.t No No 14 None 107.7 41 130/104 30 1.5 200 0.75 
5 1 t  No No ? 32 None 86.4 36 120/84 35 1.0 200 Pione 
trol of bleeding duodenal ulcer (Figure 3). 
At autopsy, fungal brain abscesses and 
pneumonia were found. In this patient, 
whose donor was a fraternal twin (blood 
group direction 0 to A), it had been neces- 
sary to use large maintenance doses of pred- 
nisone (30 to 60 mg/day) in order to main- 
tain stable renal function (Figure 3). In 
the last days of life there was deterioration 
of renal function that coincided with de- 
velopment of septicemia with Pseudomonas 
aeruginosa, Candida albicans and kruzei, 
and Nocardia asteroides. 
Grossly, the transplanted kidney was 
slightly enlarged (180 g). The capsule 
stripped easily, and the subcapsular surface 
was smooth. On section, the cortex ap- 
peared pale and contrasted with a deep 
red medulla. The renal pelvis and ureter 
were normal with no evidence of stricture 
at any point. The main renal vessels and 
their anastomoses were free from thrombus 
or fibrous narrowing. 
TABLE 2. Mortality and Survival in Patients Who 
Received Renal Homotransplants 4 Months or 
Longer Ago (November, 1962, to February, 
1964)* 
Total number of patients 
Died within the first 4 months 
Survived for at least 4 months 
Died after 4 months 3 
Survived to date (June, 1964) 30 
Total transplanted 1 year ago or longer 12 
Survived for 1 year or longer (longest 
survivor 183 months) 5 
* As of June 10, 1964. 
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FIGURE 1. Course of Patient LD 6, who received a homograft from his younger brother on 
April 17, 1963. Both were 0 blood type. Thymectomy was carried out 26 days before transplan- 
tation. Splenectomy and right nephrectomy were performed at the same time as homotrans- 
plantation; the left kidney was removed 1 week later. A rejection crisis that occurred 18 days 
postoperatively was reversed with prednisone and actinomycin C. Sreroids were discontinued 
after 5 months. The patient has normal renal function in June, 1964. 
Microscopically, the glomeruli were hy- 
pertrophied and there was some periglo- 
merular fibrosis but no other changes were 
seen in the tufts. Widespread and severe 
tubular atrophy was present (Figure 4) 
together with some birefringent calcium 
oxalate crystals. Recent tubular necrosis, 
casts, and calcification were not present. 
There was a very mild cellular infiltration 
consisting mainly of plasma cells with a 
few small lymphocytes and very occasional 
T h e  second patient ( L D  20), a 5-year-old 
boy of 0 blood type who received an A 
group maternal homograft, survived for 
202 days. Two months before his death 
he suddenly developed convulsions and 
deep coma from which he never aroused. 
There was no evidence of late rejection. 
Permission for autopsy was denied. 
A third patient ( L D  lo),  who died at 
295 days of an uncontrolled late rejection, 
is considered in detail below. 
larger pyroninophilic lymphoid cells. Inter- 
RE,ECTION 
stitial fibrosis was diffuse and prominent Evidence of delayed rejection was ob- (Figure 4). There was no Scat- served in 6 patients 4 months or longer 
tered hyphae and were after o~eration (Table 3). In one ILD 10). 
, . 
present with no re- the prdcess was Lot contrblled. ~ h e ' ~ a t i e n t ,  
action. Many peritubular capillaries had a 46-year-old man of O+ blood type, re- 
. - been completely destroyed, but the arteri- ceived a homograft from a volunteer con- 
oles and veins were normal. There was vict donor whose blood group was 0-. 
very slight fibrous intimal thickening affect- Steroids were withdrawn unusually rapidly 
ing a few of the interlobular arteries. because of a series of early complications 
T. E. STARZL ET AL. Ann+.of Internal Medlc~ne 
-W 0  1 0 2 0 3 Q 4 0 5 0 6 0  
FnE-w 
-10 0  1 0 2 0 3 0 4 0 5 0 6 0  
TIME bN DAYS -sCLtW" 
FIGURE 2. Use of steroid pretreatment in a patient (LD 47) who received a homo- 
graft from his brother. Both were A blood type. Three days after operation, acute 
wound tenderness, hematuria, and anuria developed. Immediate relief followed 
the first dose (150 r) of transplant irradiation. Restoration of function was so 
rapid that creatinine clearance, which was based on a 24-hr urine collection, 
had only slight depression although early azotemia is evident. A second reversible 
rejection occurred at 14 days with recurrence of renal failure, weight gain, and 
temporary depression of white count. Note that steroids completely masked the 
fever of rejection. The patient has normal renal function in June, 1964, more 
than 150 days after operation (see Table 1). 
(Figure 5) including myocardial infarction, 
gastrointestinal hemorrhage, and aseptic 
necrosis of the first lumbar vertebra. Pred- 
nisone was discontinued 126 days after 
operation. After 103 days the blood urea ni- 
trogen (BUN) began to rise (Figure 5). The 
homograft was locally irradiated with two 
doses of 150 r at depth, 254 and 256 days 
postoperatively with a subsequent brisk 
diuresis and rapid fall of BUN. The im- 
provement was short lived. Within 2 weeks 
progressive azotemia reappeared (Figure 
5). Prednisone was restarted first in doses 
TABLE 3. Timing of Late Rejections 
-- 
LD Days Days Reversed 
No. After After 
Opera- Steroid 
tion Change* 
- - 
10 229 103 No 
12 300 154 Yes 
13 240 20 Yes 
22 244 60 Yes 
23 223 16 Yes 
30 112 30 Yes 
* In all but LD 30, steroids had been stopped. For 
LD 30, the alteration consisted of reduction of predni- 
sone from 45 to 30 mg/day. 
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URINE No 
mEq/L 
URINE 
VOLUME 
OUT PATIENT- 
AZATHlOPRlNE 
PREDNISONE 
I I I 
io 40 &J do 160 120 140 160 1 8 0  200 L FUST TRANSF'LAHT TIME IN W f S  
FIGURE 3. Course of a patient (LD 9) who had 3 separate early rejection crises beginning 
after 5, 34, and 71 days. Note decline of sodium excretion on each occasion and reversal of 
pattern with increases of prednisone doses. He died 10 days after emergency operative treat- 
ment of a bleeding duodenal ulcer. At autopsy, multiple fungal brain abscesses were also 
found as well as pneumonia. Total survival was 207 days. This patient had a thymectorny 85 
days before homotransplantation. 
of 20 mg/day and later with 200 mg/day 
to which a course of intravenous actinomy- 
cin C was added. The progressive renal 
failure was not halted, and the patient died 
295 days after homotransplantation. The 
last BUN was 165 mg/100 ml. Terminally, 
multiple pulmonary embolization occurred. 
The patient became hypertensive for the 
last 40 days of life with blood pressures in 
the 170/90 mm Hg range. 
Grossly, the homograft was greatly en- 
larged (260 g). The capsule stripped easily, 
leaving a pale subcapsular surface speckled 
with a few tiny hemorrhages (Figure 6). 
On section, the cortex bulged. The renal 
pelvis, ureter, and the main renal vessels 
were normal and unobstructed. 
Microscopically, the glomeruli were hy- 
pertrophied, and in some there was exten- 
sion of fibrinoid necrosis from affected 
afferent arterioles into the tuft capillary 
loops (Figure 7). Periglomerular fibrosis 
was present in a few. Scarring of the tuft 
and loss of the glomeruli were not promi- 
nent features. The basement membrane of 
the tuft capillaries appeared normal, and 
there was no juxtaglomerular hyperplasia. 
Many of the tubules were atrophic and 
lined by flattened epithelium, but there 
was evidence of continuing regeneration. 
A few of the proximal convoluted tubules 
showed acute necrosis, and these contained 
casts of protein. , 
In the interstitium there were focal col- 
T. E. STARZL ET AL. 
lections of cells. This was not a heavy infil- 
tration ant1 consistetl mainly ol small lym- 
~~hocytcs,  plasnia cells, ant1 lyrnl>hoitl c.clls 
of ~ariocts s i~es  but each wit11 a large nu- 
cleus, prominent nucleol~ts, ;rncl pyi.onino- 
pliilic cytol>lasiti. Mitoses were no1 seen. 
Thcr-e was wiclcsprcatl librosis ant1 some 
ctleiiia. 
Tllel-e was Gbi-inoid necrosis of thc ~valls 
oC some alfei-cnt arterioles ;und interlobular 
rir~crics, ant1 adjaceilt to some oC these nc- 
ci-otic lesions Irere local in~crstitial heinor- 
rhages. 111 sollie in~erlobular :~rtcrics there 
were drposirs G C  fihrin and plarelers on the 
tl;iniagctl intima. Other ni-rerics sliowccl 
Annals of 
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~r ia~ket l  narrowing 01 their lumens by fi- 
brous intinla1 thickening (Figuie 5). 
Five other paricnts (LD 11, 13, 22, 23. 
allel SO) had more or less clcail) tlocu- 
rncntctl Iiatc ~ejetr ion occurring I I? to SO0 
(lays after ol)c~ation (Table 3). T h e  homo- 
grafts in 1hc5e cascs .rifere obtrrincd lion1 
nonrclatetl tlonois in two (Figu~es 8 ant1 
9), a sil,ling in otic (Figure 10). and from 
mothers in two (Figure 11). The events 
preceding rcjcction wcre similar to those 
in the patient dvscriberl a b o ~ e .  Goocl ienal 
function hat1 hccn ~naintainccl clejpite p ~ o -  
g1e5sive ;~ttc~iualion or cornl~lc~c tliscon- 
t i~ iua~ i t e  ol the slcloicl ~hci;ip)r. Sixleeii to 
15.1 (1.1)s ;iL~ei slo1)ping (lie s r c~  oiclr (Figules 
8, 10, zinc1 11) 01 tl~ol>l)ing ~I ie  dose t o  
Lelo~\? '15 ~ng/tlay ( I : ~ ~ L I I c  9) clccli~~cb in 
c I c,~tiiiinc cle.ti ant c we1 e riorccl, usu~illy 
l~elorc L i ~ i y  (1i;ingc 1i:id oc ( 111 I c(1 in rlir 
BUN.  111 o11c asyiiil,toiiiati~ l)dtic~i(, ~ l l e  
tlct linc 01 rou~incl) rlctei~iiinetl c I catini~ic 
tlcaralice was (lie ollly finding (F iqu~c  11). 
0 r thos t ;~~i r  dtlkle cclcnia .i\~a5 noticed by 
others late in the, tlay. Kdpitl 105s ol Iiaii, 
low-g~ailc lever, rnalaise, joint pains, and 
loss 0 1  apl)ctilc wcrc all ol-,sclrctl in nioic 
~1i:ui one but riot it1 all the c,lse\. .\ scnse 
of lullness ant1 slight tentIonc\s in tlie 
~ra~isplanl  site cnablcd L.rro ~)aLicntz Lo sup 
pert tlie diagnosis. 
DIFFERENTIAL DIAGNOSIS OF LATE REJECTION 
, . I he diagnosis of I;lte rejection rnusL be 
made hy exclusion oL' other c;luscs for late 
rcnal failure inclutling chronic pyelonc- 
phritis, occlu\ion oC ~ h c  artcrial anastomo- 
sis, ;111cl ureteral o1)struction. Esan~inatiori 
of the ti\sucs after ncetllc biopsy has not 
been done because of the notentis1 risks. 
FIGURE 4. Two photomicrographs of thc renal 
I~omotransplant I~on i  Paticnt LD !) who dicd at Insteatl, the principal emphasis is on tlctcc- 
207 days. ~ ~ i ~ ~ t i ~ ~  cpisotlrs at 5 ,  34, and 71 days lion of r~lcchanical or ~ ~ [ ~ C L ~ O U S  colnplica- 
had bkcn a ~ ~ c c s s f u l l ~  I-cvcrsctl. i\. Thcre is midc- lions that arc correctable. Failing to fincl 
sprcad tubular atrophy ant1 interstitial fibrosis, these, vigorous an~ircjection nieasures are I~ut  very little ccllular infiltration. Hcmntosylin . . 
;111rl tosin stain, :.: 150. n. The at,scnce of pcri- institured. 
rubul;~r capill;~rics sho~iltl be noted. ;\ clilatcd ?'lie physical findings of late rcjcclion 
:~~roph ic  tubule (arrow) is linctl by flattcncd rc- 1i:ive I ~ e e ~ i  ; lmost ~)atl~ognoil.io~~ic. es1)e- 
gcrlcratir~g epitliclium. Hcrnatoxylin and cosin 
stain, x 250. cially i f  carelul esiimiii;ition v7as  conrluctccl 
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FIGURE 5. Course of a patient (LD 10) who died of late rejection 295 days after homotrans- 
plantation. The donor was unrelated. The diagnosis of rejection was first made at 229 days, 
but effective adjustments in therapy were not made. Note the transient fall in blood urea 
nitrogen after local irradiation of the transplant. Vigorous therapy was withheld for too long, 
and uremia became progressive and irreversible. Terminally, he had multiple pulmonary emboli. 
and recorded by the same physician during 
preceding follow-up visits. The homograf t 
that may have been nontender and almost 
impalpable became painful and prominent 
in each case. Slight local edema of the 
transplant wound was seen in addition to 
the collection of fluid in the lower extremi- 
ties. Usually these changes evolved over 
a period of several days or even weeks. 
Blood pressure rises above those previously 
recorded were present in all but one of 
the six cases. Three of the six patients de- 
veloped low-grade fever. 
The renal failure of delayed rejection 
was desultory in comparison to that which 
occurs in the immediate postoperative pe- 
riod (Figures 7-11), a fact that added to 
the difficulty of establishing a certain diag- 
nosis, but that also made practical the 
systematic employment of certain proce- 
dures before subjecting the patient to an 
intensified course of immunosuppressive 
therapy. Multiple urine cultures were im- 
mediately obtained. Urine electrolytes were 
determined. A falling sodium concentra- 
tion has the same diagnostic significance 
as with an acute rejection episode (2). The 
demonstration of increased proteinuria 
strongly supports the diagnosis of rejection 
(7). 
If rejection was suspected because of de- 
clines in renal function or because of the 
other symptoms or findings described 
above, the first special examination was 
often a radioisotope renogram using so- 
dium orthoiodohippurate-1131 as suggested 
by Collins and his associates (18). Inferen- 
tial information concerning the renal cir- 
culation can be quickly obtained in this 
way. If a sharp vascular phase is demon- 
strated, the likelihood of vascular failure 
is greatly decreased. It has not been found 
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necessary to perform dye arteriography in 
any case, and no occlusi\~e lesions have been 
found. 
T h e  radioisotol)e renogranl is of limiletl 
\:;due, ho~vever, in differentiating rejections 
from ureteral obstruc~ions. Similar curves 
have been ob~ained in both situations. 
Poor cscretion o l  the dye has been observed 
in a patient (LD SO) who had been shown 
by intravenous pyelography 3 weeks previ- 
ously to have normal ureteropelvic drain- 
age. Increased in~munosupprcssive treat- 
. , 
. # 
. 
1:rc:unl: 7. Two pho~ornicrogr;lpI~s of the renal 
l~ornotransplant from Paticnt LL) 10 w~ho died at 
295 days in a I-ejection phase. A. There is fibrinoitl 
necl-osis (arrow) of part of the wall of an affcrent 
;~rteriolc with extension of the process into the 
glomerular tuft capillaries. T h c  tubules are 
atrophic and the interstitium shows fibrosis and 
some cdema. Hematosplin and eosin stain, X 350. 
1%. An arcuatc artery shotvs marked fil,ro~~s intimal 
thickening. ElasticIvan Gieson stain, x 200. 
ment caused reversion o l  the culve LO 
normal. T h e  immediate improvement in 
function which followecl augmentation ol' 
anlirejection therapy suggested that the 
dclayed exc~ction may have been due L O  
interstilia1 edcrna and compression of the 
intl arena1 collecting syslern. i-\lmos~ idcn- 
tical curves have been seen in 3 casc 
(LD 27) in ~vhich the cause ~vas later 
Frt.u~l: 6. 1-Ion~og~nft from Paticnt LD 10, as proved to be due LO a midureteric stricture 
acen at  autopsy 295 days aftcr operation. Upper that lequirecl surgical repair. 
photog~aph: ;hc capsule is partly-stripped, show- Because the loss of renal function is grad- 
ing the smooth subcapsular surface with occasional 
tiny pctechial Ileruorrhagcs and persistent fetal U'', P Y ~ ~ ~ ~ ~ ~ P ~ ~ ~ ~  .iTisualization of the extra- 
lobation. Lower photograph: the cut cortcx bulges renal collecting syslem is usually possible 
o\er the capsulc. and a few pinpoint cortical hcm- if a re-inforcing dye dose of contrast ma- 
onhages arc prcscnt. Othcnvise, thc appcarance is 
normal. \\'eight was 260 g. terial is given. T h e  demonstration OE a 
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FIGURE 8. Severe delayed rejection in a patient (LD 23) who received a honiograft from an 
unrelated donor. Note rises in blood urea nitrogen and declines in creatinine clearance after 
discontinuance of steroid therapy. Creatinine clearance began to rise after institution of emer- 
gency therapy, although the azotemia became temporarily worse. Further improvement in 
renal function continued after preparation of this graph; during the last 2 weeks of May, 
1964, and the first week of June, 1964, creatinine clearances averaged 85 mllmin and blood 
urea nitrogen averaged 32. 
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(mgm /day) loo 
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FIGURE 9. Delayed rejection in a patient (LD 30) who received a homograft from an un- 
related donor. Deterioration of renal function occurred after reduction of prednisone from 45 
to 30 mg/day. Note transient improvement after a course of local transplant irradiation. 
Stable renal function was not obtained until the steroid doses had been returned to the previous 
higher levels. 
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FIGURE 10. Late rejection (Patient LD 12) appearing 300 days after homotransplantation and 
6 months after discontinuance of steroid therapy. The homograft was provided by the patient's 
brother. 
normally draining ureter and pelvis greatly tained, retrograde visualization should be 
strengthens the possibility that rejection attempted since several partial ureteral 
was a cause of the diminished excretory blocks have been encountered, as will be 
capacity. If dye concentration is not ob- described in the ensuing section. 
PT. M.S.P. 
60 MYS- 
PREDNISONE 
FIGURE 11. Delayed rejection in a 15-year-old boy (LD 13) who received a kidney from his 
mother. After steroids were stopped, there was a gradual fall of creatinine clearance. The 
patient had no symptoms. Note gradual restoration of creatinine clearance after the institution 
of 60 mg/day prednisone. 
\ 'olt~n>e 6 1 ,  Tn. 3 
Sc[) t~ .mb~>r  1'10.i 
LATE UROLOGIC COMPLICATIONS 
FICUKI. 12, I~ntravenous pyclogram 4 months after 
l lomot~~, t~rar ) l~~r~ta t ion  in Patient LL) 39. A contrast 
ilrtcnsificariou tccllnique was used. Note the par- 
tial obs[~llction at thc urcteroncocystostomy. At a 
sl~bsequerlt scconclary operation, the proximal ure- 
tcr of the l~omograft was anastomosed to the pa- 
tient's own right ureter, which had not bcen 
rcmorrd at the time of thc original right neyl>-l-p- 
lomy. T h e  result was satisfactory. 
T h c  lew cxamples of late ulologic corn 
plications alter transplantation  ha\^ been 
leportcil although il is hno.cvn  hat one o l  
Mnrmjl's irlentical twin recipients has de- 
velopcrl rcnal stoncs (19), and that one of 
the patients in the St. h,i;~ry's 1-Iospital se- 
I ies t1evelol)etl ulinary extra\lasation Inole 
tlian 100 clays alter ~rans~>lantation (20). 
In  the 1xcsenL series of palien~s, late 
111ete1 ic obs~iuction Ivas seen on four occa- 
3ions. In  thlce ol these, the sterlosis was 
as) rnptonlalic, being detectecl by routine 
int~a\icnous ~'yelography. In thesc three, 
rhc narrowed area was at the site of im- 
l~ ldnta t~on  inlo the bladtler ( F i g ~ ~ r e  12). 
T h e  obstructive uropathy was relieved in 
cach case by re-operation and pelformancc 
of anastomosis of the pelvis or uretero. 
pelvic junction to the patienl's own ipsi- 
lateral or co~ltralateral ureter. The  utility 
of this type of procedure in t rea~ing coni. 
plications at the blacltler implantation sile 
-10 0 10 20 30 42 60 80 100 IX) 140 160 120 190 200 210 220 230 240 260 260 270 280 
I IS c.- , W E  
-- TIME IN DAYS *NOTE CHWE IN SCILE 
1 l c . u ~ ~  13. Coursc of a 21-year-old wornan, L1) 27, who received a homograft from an un- 
~cla ted  male donor. Both wcre of A blootl typc. Early postopcralivc rejection was very mild. 
.4frcr 190 days, she siltltlcnly bccame anuric, subscquently alternating with bouts of brisk 
~liuresis. Although she was treatcd as an acute rcjcction, it was subscquently tlcmonstratcd that 
she had severe midureteric stricture that was t l~ought to be a consequence of late healing that 
f<rllowrd a previous rejection. After corrcction of the mechanical difficulty she has been well. 
T. E. STARZL ET A Annals of !ntcrnnl LI~dicine 
enlphasi~es the advisability of not perform- 
ing ureterectorny cxcept for specific indi- 
cations at the time the patient's own tlis- 
based kidneys are excised. 
In the fourth patient (LD 271, the cause 
)f the obstrnctive ulopathy could not be 
~rad i ly  cla~sifietl, and this case will bc de- 
scribed separately because o l  the possibility 
that this represented a late complication 
of a previous rejection. A 21-year-old 
~ t~onlan  recei\ied a homogral~ f ~ o n l  a con- 
\ict donor on September 3, 1963. 
was only equi\.ocal evidence o l  carly rc- 
jection after which she had stable renal 
function u n ~ i l  h' la~ch IS, 1964, by ~ t ~ h i c h  
time her prcdnisone dosc had been leclr~cctl 
to 10 mg/day. Aftcr a sevele bout o l  di- 
anhca  induced by castor oil, anuria dcvel- 
oped that lasted for 5 clays. 
Enlergency antirejection measures wcre 
taken wit11 high doses of steroids, actino- 
inycin C:, and t~tro courses (total. YO0 r) of 
local irradiation. During the next scve~al 
weeks, anuria or oliguria alternated with 
cliuresis (Figure 13). An intravenous pyelo- 
gram obtained during a cliuretic phase 
sho.tved obstruction high in the ureter (Fig- 
ure 14). Ultimalely, she was treated with 
anastoniosis of the prosimal homografted 
ureter to the distal portion oE her own 
ipsilateral ureter on April 18, 1964. Re- 
overy was uncomplicated (Figure 14). 
Tha t  portion of the midureter that was 
emoved at the time of re-operation had 
a high-grade internal stricture extencling 
orer at least 1 in. Microscopically, there 
was severe fibrous thickening of the intima 
and rupture oE the internal elastic lamina 
of  he majority of  he arteries in the wall 
of the affected segment. In  acldition, there 
was much muscle necrosis, a heavy cellular 
infiltration and virus inclusion bodies. This 
case and several otllers in  which ureteric 
and pelvic lesions were seen are considered 
in detail in another communication and 
their relationship to previous rejection epi- 
sodes discussed (21). 
FIGURE 14. Intravenous pyelograrns of same case 
(LL) 27) shown in Figure 15. Top photograph: in- 
travenous pyelograrn showing high-gmcle obstruc- 
tion of the homograft midurcter. Bottom photo- 
graph: appearance after resection of the stenoscd 
urcter and re-anastomosis to the patient's own ipsi- 
lateral ureter. The anastornotic site is shown wlth 
an arrow. The sorncwhat dilated distal portion is 
the patient's own urcter, which had previously 
heea dcmonstratecl to have rcflux. 
TREATMENT O F  DELAYED REJECTION 
T h e  same therapy is effective as that 
previously described for reversal of rejec- 
tion occurring early in the postoperative 
period (2, 5, 7, 9-12, 14). T h e  slotv devel- 
opnlent of delayed iejeclions observed in 
the present seiies made it possible in some 
instances to evaluate the elTect of individ- 
ual agents. Thus, local transplant irradia- 
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tion (Figures 5 and 9) and increased dos- 
ages of steroids (Figure 11) were both 
shown to be of therapeutic value when 
used alone in one or more isolated cases. 
However, in one patient (LD 10) in 
which these agents were used serially, re- 
mittent deterioration continued until the 
secondary renal failure became irreversible 
despite the fact that urine excretion was 
never less than 1,000 ml/day. Although the 
homograft had serious histologic abnor- 
malities (Figure 7), some of the findings 
were probably reversible, including the in- 
testinal edema, had more vigorous im- 
munosuppressive measures been taken at 
once. Because of the fatal outcome in this 
case, the subsequent patients were treated 
much more aggressively, adding agents 
more quickly and sometimes in combina- 
tions (Figures 8 and 10). 
An idea of the relative roles of the vari- 
ous immunosuppressive agents in the treat- 
ment of late rejection can be obtained from 
a review of those events that invariably 
preceded the onset of this serious compli- 
cation. Since a maximum safe dose of 
azathioprine had been used in all these 
cases, with only minor variations in daily 
quantity, the inefficient administration of 
this drug did not seem to be a factor in 
the initiation of delayed rejection. Further- 
more, the previous employment of this 
agent to those limits that were compatible 
with safety of the host made further in- 
creases in dosage impractical. 
In contrast, it appeared as if stability of 
homograft function was disrupted in every 
one of these cases, either by discontinuance 
of prednisone or by reduction of this drug 
to a lower level than had previously been 
used for some time. Thus, steroids had 
been stopped for Patients LD 10, 12, 13, 
22, and 23. Rejection was recognized 103, 
154, 20, 60, and 16 days later, respectively. 
Patient LD 30 began to reject 30 days after 
reduction of prednisone from 45 to 30 mg/ 
day. 
Because of the apparent dependence 
upon continued steroids for stable homo- 
graft function in such cases, the most im- 
portant immediate alteration was thought 
to be prompt resumption of prednisone 
administration or an immediate dose in- 
crease for those patients who were already 
receiving slowly diminishing steroid main- 
tenance. The extent to which the steroids 
must be employed in the treatment of late 
rejection is not known with any degree of 
certainty. In view of the fatal outcome of 
the one case in which small doses were 
first tried (Figures 5) ,  three of the subse- 
quent cases were treated with drastic in- 
creases (Figures 8, 10, and 1 l), which were 
continued until unequivocal evidence of an 
improvement in function had been sus- 
tained for several weeks. The most impor- 
tant objective measurement of excretory 
capacity was creatinine clearance since mis- 
leading elevations in BUN persisted de- 
spite improvement in other measures of 
function, apparently because of steroid- 
induced increases in catabolism. 
Later, when clear evidence of reversal 
had been obtained, the steroid doses were 
slowly reduced (Figures 8 and 11). The 
success with which return to small daily 
doses can be achieved is yet to be deter- 
mined, although it seems likely that con- 
tinuation of prednisone in doses of 20 to 
40 mg/day will be required for many 
months and possibly even for the remainder 
of the patient's life. 
Additional promptly directed immuno- 
suppressive therapy was used at the time 
of late rejection, particularly when a diag- 
nosis was not made early and when the 
degree of renal impairment was more than 
slight. Actinomycin C and repetitive local 
irradiation of the homograft (Figures 8 to 
10) were used in the same way as has been 
previously described for the treatment of 
early rejection crises, X-ray therapy (11, 
13, 14) being of the greatest immediate 
value. After the first application of 150 r, 
the sense of fullness or pain over the trans- 
plantation site was immediately relieved 
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in every case. Reduction in the size of the 
homograft was noted by palpation. 
Although the value of these adjuvant 
immunosuppressive procedures, especially 
local irradiation, seems real, they should 
not be used as the sole adjustment of treat- 
Tent for several reasons. Although tempo- 
rary improvement in renal function can 
be expected, it occurs against the back- 
ground of that therapy that has already 
proved to be insufficient. Furthermore, the 
chronic use of the added agents, which 
~rould presumably be necessary if steroid 
therapy were not intensified, has serious 
disadvantages since actinomycin C,  which 
is probably only of moderate effectiveness 
in any event, has important systemic tox- 
icity that makes its protracted use undesir- 
able (2). Alternatively, repeated courses 
of local X ray would involve the risk of 
producing irradiation injury to the homo- 
graft. The use of local transplant irradia- 
tion and actinomycin C should, therefore, 
be viewed as temporizing during an emer- 
gency and should coincide with the defini- 
tive alteration in steroid management. 
Annals of 
Internal Medicine 
LATE RENAL FUNCTION 
Adequate, if not normal, renal function 
was obtained from virtually all homografts 
that were still functioning after 4 months. 
The last creatinine clearance and BUN'S 
are listed in Table 1 for each patient in 
the series who lived for more than 4 
months. The lowest creatinine clearance in 
any of the patients still alive in June, 1964, 
was 27 ml/min (LD 41, a 3-year-old child), 
and fihe highest BUN was 54 mg/100 ml 
(LD 30). The mean values for the 30 cases 
still being followed were 88.1 ml/min for 
creatinine clearance, and 23.7 mg/100 ml 
(BUN). Although these figures are impor- 
tant in making clear the fact that generally 
good homograft function can be obtained, 
it should be again emphasized that trends 
in function are of greater prognostic sig- 
nificance than any individual determina- 
tion. Thus, a patient whose creatinine 
clearance has dropped from 100 to 70 ml/ 
min may pose a far more serious problem 
of late management than another who has 
a stable creatinine clearance of 50 ml/min. 
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FIGURE 15. Chronic course of Patient LD 2 who received a homotransplantation from his sister 
in January, 1963. The patient was of A blood type. His sister was B. Note progressive improve- 
ment in creatinine clearance, starting after 3 postoperative months. Prednisone was discon- 
tinued after 230 days. The patient had a preliminary thymectomy. 
V o l u n ~ c  61. S o .  3 
Sr~>Lcmber 1'164 
I:rc.unc 16. Appcarancc of aspctic necrosis of the fc~nornl hcad in two young rvomcn after 
L~dnspla~~tation. Both wcle on prednisone therapy at the time of this dclaycd compl~catron. 
LIppcr p l ~ o ~ o g r ~ p l ~ :  P a t i c ~ ~ t  LD 22. Lower photograph: Patient LD 50. 
I n  those patients followed for the long- 
est times in whom delayecl rejeclion has 
no1 adversely affected the lale course, the 
function has tentled to improve with h e  
passage of time (Figures I and 15) so that 
functional hypertrophy in the recipient has 
been alnlost parallel with that of the donor. 
Thus, in Patients LD 1, 2, and 3, the crea- 
tinine clearances -1 months or longer after 
operation were 83, 91.8, and 129 ml/min, 
lespectively. Sirnnltaneous determinations 
in the three respective donors were 112, 
89.9, and 129 ml/min. Prior to delayed 
rejection and 1.16 clays alter operation, thc 
compatative creatinine cleatances in LD 12 
were 70.5 1111 lor tllc donor and 73.3 ml/ 
min for the recipient. T h e  tests have not 
been repeated since reversal of the subse- 
quent delayecl rejection shown in Figure 10. 
LATE BLOOD PRESSU 
In a previous publication, emphasis was 
placed upon the cyclic appearance of hyper- 
tension that was often a troublesome prob- 
l e ~ n  during rejection and that tended to rc- 
cede after reversal of this process (9). Since 
care was exercised to maintain normal or 
near nornlal blood pressures during early 
convalescence, most palients were placed 
on one or  more antihypertensive drugs 
during this period. T h e  ultimate bloocl 
pressure in  these patients, and the need for 
later continuation of such pharmacologic 
agrnls assumes an especial importance be- 
cause ol the \lascular lesions thal have becn 
found in many homografts studied by nee- 
tlle biopsy or at autopsy (20, 22, 23). 
Except in those cases in  which late con- 
valescence was marred by delayed rejection, 
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the tendency to hypertension and the re 
quirements for antihypertensive drugs was 
Iess with the passage of time (Table 1) and 
seemed to be directly related to the level 
of maintenance steroid therapy required 
for protection of the homograft. The av- 
erage sitting blood pressures during May, 
1964, are given for all patients in the pres- 
ent series in Table 1 as well as an account 
of the antihypertensive drugs being used 
during this time. It will be noted that none 
of the patients followed for the longest 
intervals are receiving any medication of 
this type. 
LATE DRUG TOXICITY 
Overt evidence of late azathioprine tox- 
icity has not been encountered, although 
two patients (LD 15 and 36) have devel- 
oped hepatitis 6 and 3 months, respectively, 
after operation, which was thought to be 
of viral etiology. It is possible, however, 
that this may be a manifestation of specific 
drug toxicity as Murray (7) has suggested. 
A high incidence of hepatotoxicity has been 
reported by McIlvanie and McCarthy (24) 
and by Einhorn and Davidsohn (25) after 
chronic administration of the related agent 
6-mercaptopurine to patients with leu- 
kemia. 
The consequences of protracted steroid 
administration have seemed to be much 
more serious. The high incidence of gastro- 
intestinal hemorrhage during steroid ad- 
ministration in the early postoperative 
period was previously described (26). In 
those cases followed for more than 4 
months, there have been two additional 
examples (LD 9 and 30) and in one of 
these, bleeding was an important con- 
tributory cause of death (Figure 3). Radio- 
graphic evidence of severe osteoporosis has 
been noted in many patients, and in one 
aseptic necrosis of the first lumbar vertebra 
was detected 3 months after operation (27). 
In two other young adolescent females 
(LD 22 and 50), aseptic necrosis of the 
femoral head (Figure 16) occurred 54 
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months and 5 months after operation, re- 
spectively. The prednisone doses at the 
time of these complications were 10 and 
30 mgjday, respectively. 
Immediately after transplantation, re- 
markable increases in body weight often 
occur due to an enormous caloric intake. 
In some of the patients in whom it has 
been impossible to reduce prednisone below 
20 to 30 mg/day, appetites have continued 
to be insatiable, and obesity has followed 
almost to the degree seen in the Pick- 
wickian syndrome. Both the aforemen- 
tioned girls with aseptic necrosis of the 
femoral head developed this complication 
only after gains of 10.6 kg and 11.5 kg 
over their preoperative weight. 
It has been noted by many authors that 
the necessary intensity of immunosuppres- 
sive treatment can usually be relaxed after 
the critical first 1 to 3 postoperative 
months. If this were not the case, there 
would be no hope for the useful clinical 
application of homografting procedures 
since the long-term use of maximum ther- 
apy results in immunologic crippling and 
death from complications of the agents 
employed. 
Although some degree of host-graft adap- 
tation (2, 3, 9, 28-31) seems to be common 
to almost all renal homotransplantations, 
the completeness of this change in clinical 
cases is not known. I t  is conceivable that 
the apparently well-tolerated homograft is 
under constant but imperceptible attack 
and that it will be slowly rejected over 
a period of months or years. The under- 
lying mechanism may be a gradual destruc- 
tion of peritubular capillaries by infiltrat- 
ing cells resulting in foci of tubular atro- 
phy and interstitial fibrosis. Certainly these 
changes were present in the two homo- 
transplants from the present series, which 
were examined at 207 and 295 days, and 
they have featured prominently in the pub- 
lished descriptions of other renal homo- 
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transplants, both human and dog, that 
have failed late. In addition, even without 
overt acute rejection episodes, fibrinoid 
necrotic vascular lesions may occur and if 
these involve the interlobular arteries they 
may lead to permanent narrowing of some 
of these vessels by fibrous intimal thicken- 
ing (20, 22) as in Patient LD 10. Progres- 
sive ischemia may then become an impor- 
tant feature in limiting the functional life 
of the transplant. 
PROLONGED SURVIVAL AFTER HOMOTRANS- 
PLANTATION 
In these reported cases followed for the 
longest time, justification can be found 
either for a sense of futility or of hope. 
The first chronically successful renal homo- 
transplantation was performed by Dr. 
Joseph Murray at the Peter Bent Brigham 
Hospital in Boston more than 5 years ago. 
Total body irradiation was the primary 
means of immunosuppression. Other sub- 
sequent measures to control rejection in 
this case were reported by Merrill and as- 
sociates (32) in 1960. The patient, whose 
donor was a fraternal twin, was alive in 
May, 1964, with normal renal function. 
Murray (33) in a personal communication 
reported the results of a recent complete 
evaluation of the case as follows: 
"A dizygotic twin of 54 years recently left 
the hospital after a check-up including a 
biopsy. He is perfectly normal in every way 
as far as renal function is concerned. There 
are some microscopic changes which you can't 
really interpret, not knowing whether they 
are scarring as a result of his abortive rejec- 
tion crisis of 5 years ago or whether it is 
some new very slow drain on the kidney. 
However, if we hadn't done the biopsy, we 
wouId consider him perfectly normal in every 
other way." 
Although it may be true, as has been 
suggested by Goodwin and Martin (34), 
that some degree of natural chimerism may 
have existed in the foregoing case because 
of cross-placental circulation, there seems 
to be little reason to doubt that the homo- 
graft passed through a very mild stage of 
immunologic insult. Histologic evidence of 
cellular rejection was present on an open 
biopsy specimen obtained 9 months after 
the original operation. 
The only other homografts that had 
maintained life for more than 2 years at 
the time of the Washington transplantation 
conference in September, 1963, were re- 
ported by Antoine and Hamburger (35) 
and by Shackman and Dempster (13, 36) 
and their associates. As with Murray's case, 
primary immunosuppressive therapy was 
with total body irradiation. In Hamburger's 
patient, who was operated upon a few 
months after Murray's, the kidney was also 
donated by a fraternal twin. By personal 
communication from Hamburger (37) it 
was learned that the patient was still in 
good health in May, 1964. 
The patient treated by Shackman, 
Dempster, and Wrong (13), who was 23 
years postoperative in the fall of 1963, is 
of the utmost interest since he is the long- 
est surviving human after homotransplan- 
tation between a nontwin donor and recip- 
ient. The patient who was receiving 
virtually no immunosuppressive therapy 
had only fair renal function (creatinine 
clearance, less than 25 ml/min), but there 
has been no recent tendency to deteriora- 
tion. In a follow-up on May 8, 1964, 
Dempster (38) has informed us that the 
patient is still in good condition, now 3 
years and 2 months after operation. 
These three patients with exceptionally 
prolonged survival have either not been 
subject to overt late rejection or if this 
has occurred, it has been mild and rela- 
tively easily controlled. These facts may 
give a misleading impression of the late 
expectation of other patients who have 
been treated with homotransplantation. 
The donor-recipient relationship in this 
small group of cases was highly favorable. 
The homografts were provided by fraternal 
twins in two instances and by a nontwin 
sibling in the third, groupings that greatly 
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magnify the chances of matching the anti- 
genic constitution of the donor and host. 
Furthermore, these remaining patients are 
quite obviously the further refined prod- 
uct of a sensitive biologic test system that 
ruthlessly weeded out all but those who 
fortuitously received the most genetically 
suitable homografts. The absence or mild- 
ness of late rejection in these valuable 
early cases is encouraging. It does not mean 
that delayed rejection will be a comparably 
trivial problem when the larger numbers 
of patients now receiving better early im- 
munosuppressive treatment are brought to 
a similar chronic stage. 
DELAYED REJECTION OF HOMOTRANSPLANTS 
Indeed, there is sound reason to avoid 
overoptimism at this time. Delayed rejec- 
tion has been reported long after operation, 
usually manifesting a gradual decline of 
renal function over many weeks or months 
(39, 40) just as has been described in the 
present report. Woodruff and Robson (40), 
in a personal communication, have de- 
scribed two of the most disturbing exam- 
ples in which fatal rejections occurred 15 
and 16 months after two parent-to-offspring 
homotransplantations. In the most com- 
pletely documented example of late rejec- 
tion in the literature, Kiiss and associates 
(39) in 1962 described the same events in 
a patient who died 17 months after trans- 
plantation with progressive renal failure 
that was first recognized 9 months post- 
operatively. In this case it is of interest 
that a needle biopsy 59 days after homo- 
transplantation already showed interstitial 
edema and proliferative vascular changes, 
the latter vascular changes having been 
observed by other authors (20, 23, 41) at 
an even earlier postoperative time. 
In spite of the dearth of information 
concerning late rejection, it is known that 
this problem has been encountered in other 
centers. Hamburger, Crosnier, and Dor- 
mont (5) have allowed us to read a manu- 
script that will appear in the Annals of the 
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New York Academy of Science in 1964, in 
which he describes several variants of de- 
layed homograft disease. These include two 
examples of acute rejection crises similar 
to those commonly observed in the early 
postoperative period, one at 6 and the other 
at 10 months. Biopsy in both revealed 
interstitial edema and cellular infiltration, 
but interstitial fibrosis was not mentioned. 
The process was reversed in both cases. In 
another of Hamburger's patients, who died 
of slow rejection after 22 months, severe 
interstitial fibrosis was present. 
GLOMERULONEPHRITIS IN THE TRASSPLANTED 
KIDNEY 
Hamburger and associates (5) have also 
drawn attention to the late development 
of chronic glomerulonephritis in the homo- 
graft, a complication that led to the death 
of one of his patients after 23 months. 
Although Murray, Merrill, and Harrison 
(42) had observed this in a patient with 
an identical twin isograft, it had not pre- 
viously been seen after true homografting 
procedures except in cases reviewed from 
the St. Mary's series (20), and in a case 
reported by Krieg and associates (43). It 
is of great interest that glomerulonephritis 
was also seen by Hamburger after trans- 
plantation to a patient whose original dis- 
ease was congenital interstitial nephropa- 
thy, a surprising sequence also reported by 
Krieg and associates (43) to have devel- 
oped within a few days in a patient who 
had originally had pyelonephritis. Whether 
this "glomerulonephritis" observed in ho- 
mografts has the same pathogenesis as that 
disease commonly seen in clinical practice, 
or is some variant of rejection, remains to 
be clarified. 
LATE OBSTRUCTIVE UROPATHY 
It has become increasingly clear that 
life-threatening problems other than rejec- 
tion will also have to be detected and 
effectively treated if the residual popula- 
tion of homotransplanted patients is to 
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be maintained and that ureteral obstruc- 
tion may prove to be amongst the foremost 
of these. Four of the 33 patients in the pres- 
ent series who lived for 4 months or longer 
developed hydronephrosis. Although re- 
constructive procedures were possible in 
each, the necessary secondary operations 
were formidable ones and can be expected 
to carry a high risk. One of these 4 patients 
(LD 44) has a chronic partial urinary fis- 
tula after repair will probably require an 
additional reconstructive procedure. In 
some patients the ureteric block may prove 
to be due to healing of previous ureteric 
rejection as seems to have definitely oc- 
curred in one case (LD 27) of the present 
series. Similar late ureteric damage without 
obstruction was noted in a patient of Kiiss 
and associates (11) who died after 490 days. 
TOXICITY OF DRUGS 
In addition, more information is needed 
concerning the toxicity of those drugs that 
are being administered. Perhaps it is nat- 
ural to focus undue attention on the func- 
tion and well-being of the homograft, 
sometimes almost to the exclusion of the 
beneficiary of this unnatural gift. In order 
to retain viability of the transplant, altera- 
tions in the host are inevitable. Some of 
these are obvious, others are subtle but 
measurable, but most of the changes are 
probably not even yet known. The ultimate 
toxicity of azathioprine, for example, in 
terms of a possible increased incidence of 
blood dyscrasias will take years to deter- 
mine. The influence of this drug on re- 
productive physiology requires additional 
study. One of the male patients (LD 6) in 
the present series recently became the 
father of a normal child, which was con- 
ceived during the postoperative period of 
azathioprine therapy. Unpublished experi- 
mental studies by Dr. John A. Githens (44) 
of the University of Colorado Department 
of Pediatrics indicate that spermatogenesis 
is not seriously disturbed by this drug, but 
that its chronic administration to females 
induces a high incidence of anomalies in 
the offspring. 
In the presently reported series, the 
chronic use of azathioprine has not by it- 
self seemed to cause unacceptable toxicity 
in the late stages of recovery. Those pa- 
tients now receiving only azathioprine 
enjoy a remarkably good state of health, 
most being 1 year or longer after operation 
(Table 1). That late toxicity from the mer- 
captopurine drugs is to be feared, how- 
ever, is illustrated by one of Kiiss and asso- 
ciates' cases (45) in which fatal agranulo- 
cytosis abruptly terminated the course of 
an otherwise succesfully treated patient 
after 18 months. 
Although relatively chronic therapy with 
azathioprine carries an apparently accepta- 
ble risk, the superimposition of large ster- 
oid doses can be said, even now, to add a 
significant element of morbidity. As was 
described, one patient receiving this com- 
bination required emergency surgery for 
control of bleeding duodenal ulcer and 
was also found at subsequent autopsy to 
have fungal brain abscesses (LD 9). Three 
patients with aseptic bone necrosis and the 
frightening prospect of massive obesity in 
others add to the timorousness with which 
the steroids have been continued. 
In small children, the continuous use 
of large doses of steroids has in some re- 
spects an especially ominous significance. 
The alarming weight gains already de- 
scribed can be life-threatening because of 
mechanical respiratory embarrassment. 
Bone growth may be limited or arrested 
if it is impossible to make substantial early 
reductions in dosage. Fortunately, the three 
youngest patients who are still alive have 
either had prednisone discontinued (LD 1) 
or reduced to 5 mg/day (LD 34 and 41). 
Nevertheless, the last two patients still have 
residual evidence of hypercorticism. 
LATE "HOMOTRANSPLANTATION DISEASE" 
Finally, it seems important that certain 
other poorly understood manifestations of 
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late "homotransplantation disease" be 
clarified. Recently a late febrile syndrome 
was described, accompanying steroid with- 
drawal (2), during which a peculiar and 
life-threatening pneumonic process was fre- 
quently observed (46). The cause of this 
late febrile syndrome is not known, but 
it may be a variant of the "late extrarenal 
syndrome" described by Hamburger, Cros- 
nier, and Dormont (5). Several of their pa- 
tients developed delayed fever, splenomeg- 
aly, hepatic dysfunction, and hypergam- 
maglobulinemia. Hamburger has suggested 
that these findings may due to the estab- 
lishment of an imperfect chronic equilib- 
rium between the host and the homotrans- 
planted kidney. 
This detailed analysis of the late prob- 
lems after renal homotransplantation has 
not been undertaken with any sense of pes- 
simism or as an attempt to dampen the 
enthusiasm for those accomplishments that 
are already a part of recent history. It is 
clear that a remarkable change in the early 
postoperative outlook after homotrans- 
plantation has taken place at several insti- 
tutions during the last 2 years. By personal 
communication in May, 1964, it was 
learned that Murray (33), Hamburger (37), 
Hume (47), and Kolff (48) all had a half 
dozen or more patients living essentially 
normal lives more than 6 months post- 
operatively. Of the first 64 patients at the 
University of Colorado Medical Center 
treated from November 24, 1962, to March 
30, 1964, with homografts obtained from 
living donors, 47, or 74.4%, survived for 
more than 2 months, and of this group 40, 
or 62.5%, were still alive on June 10, 1964. 
Thirty of these surviving patients were 
more than 4 months postoperative on this 
date, 25 were more than 6 months, and 
5 were more than 1 year. Thus, the first 
hurdle of the transplantation problem has 
been at least partially breached in that a 
state of relatively protracted homograft 
function can be attained in considerably 
more than half the cases. 
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With this change has come a shift in re- 
sponsibility for those institutions perform- 
ing clinical investigation in renal homo- 
transplantation. A change in emphasis has 
now become essential to obtain data that 
will help in providing maintenance care 
and establishing long-term prognosis since 
it is evident that many pitfalls remain, and 
that the most obvious of these relate to the 
necessity of continuing steroid therapy for 
protracted periods of time. 
THYMECTOMY 
In this connection, it seems pertinent to 
review the possible influence of thymec- 
tomy on the late results after homotrans- 
plantation. It was noted earlier that eight 
of the first patients received preliminary 
thymectomy (15) in preparation for trans- 
plantation. This adjuvant procedure, per- 
formed through a sternum-splitting incision 
in patients with terminal uremia, proved 
to have a high technical risk. In addition, 
the early course after homotransplantation 
did not seem to be different from that ob- 
served in patients who did not have the 
added operation. Consequently, the use of 
this procedure was discontinued until long- 
term follow-up could be obtained on those 
patients for whom it had already been 
employed. 
The inefficacy of thymectomy in prevent- 
ing or temporing early rejection does not, 
of course, rule out the possibility of later 
benefit. Theoretically, this might, in fact, 
be consistent with what has been learned 
of thymic function by Miller (49, 50) and 
others from experiments on lower animals. 
It might be anticipated that the reactivity 
of immunologically competent cells already 
present throughout the body would not be 
affected by thymectomy so that the inten- 
sity and immediacy of early rejection would 
not be altered by this operation. If, how- 
ever, the thymus is in some way necessary 
for continued replication of immunologi- 
cally specific strains of host cells, these cell 
lines might be expected ultimately to 
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undergo drastic reduction under the com- 
bined influence of unrelenting immuno- 
suppressive therapy and the continuous 
antigen loading provided by the homograft. 
Four (LD 1, 2, 3, and 6) of the original 
eight patients are still alive from 14 to 18 
months after homotransplantation. All 
have normal renal function. In each in- 
stance maintenance therapy with predni- 
sone was discontinued on or before 270 
days, and in one (LD 3) it was never re- 
quired. Both in those who did (LD 1 and 
2) and those who did not (LD 3 and 6) have 
a serious rejection crisis, there has been no 
evidence whatsoever of late deterioration 
of renal function. 
Consideration of the fate of the unsuc- 
cessfully treated four patients who had 
removal of the thymus might be important 
in assessing the possible role of this pro- 
cedure in the long-term outlook. Unfor- 
tunately, this does not seem to be the case 
since all of the patients either died in the 
early postoperative period (LD 5 and 11) 
or at a later time from complications other 
than renal failure (LD 4 and 9). The posi- 
tion could be taken that thymectomy did 
not receive a fair test in any of the latter 
four patients. 
There is at present insufficient informa- 
tion to permit even tentative opinions 
about the potential delayed value of thymic 
excision after homotransplantation. Most 
of the canine experimental work designed 
to test the influence of this operation has 
focused upon earlier postoperative events, 
partly out of necessity since the yield of 
chronic survivors in dogs is much less than 
after clinical renal homotransplantation. 
In  our own laboratories, survival for as 
long as a year has not been achieved in any 
animal initially treated with thymectomy. 
The dogs with greatest longevity, including 
two that have not required immunosup- 
pressive therapy for almost a year (3), did 
not have thymectomy. 
Nevertheless, the question of whether or 
not to remove the thymus gland is by no 
means settled. Indeed, the observations 
cited above from experience with the earlier 
human cases emphasizes the urgent need 
for further clinical evaluation of this pro- 
cedure. With the small group of patients 
now under study, it will be impossible to 
determine if thymectomy contributed to 
the ease of late management and to the 
rapidity with which steroids could be dis- 
continued altogether since in each of the 
four cases the donor-recipient genetic rela- 
tionships were highly favorable, and the 
outcome may have been the same with or 
without removal of the thymus. 
Fifty-one patients were treated with 
homografts obtained from both related and 
nonrelated volunteer donors in the interval 
from November 24, 1962, to February 10, 
1964. Thirty-three of the 51 patients lived 
for 4 or more months postoperatively, and 
30 of these are still living on June 10, 1964. 
The three deaths which occurred after 4 ~ 
months were due to a combination of 
gastrointestinal hemorrhage and sepsis in 
one; to a cerebrovascular accident of un- 
determined etiology in the second; and to 
uncontrolled late rejection in the third, 
which was first diagnosed 229 days after 
operation, 66 days before death. The two 
homografts examined at autopsy after 207 
and 295 days were both enlarged and 
showed glomerular hypertrophy, tubular 
atrophy, mild cellular infiltrations, marked 
interstitial fibrosis, and destruction of peri- 
tubular capillaries. The case that died in 
uncontrolled rejection also showed inter- 
stitial edema and a spectrum of vascular 
lesions. 
Late nonfatal rejection was observed in 
five other cases 112 to 300 days postopera- 
tively. In all these cases, and in the unsuc- 
cessfully treated one as well, certain con- 
sistent features were present. There had 
always been a preceding alteration in 
steroid dose, prednisone having been dis- 
continued in five of the six patients from 
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16 to 154 days previously? Progress of the 
rejection was slow, and the proper diag- 
nosis depended most strongly upon demon- 
stration of a gradual fall in creatinine 
clearance. Elevations in blood pressure, 
transplant wound tenderness, fluid accumu- 
lation, alopecia, polyarthritis, fever, malaise, 
and anorexia were all observed. Azotemia 
was a late finding. 
The diagnosis of late rejection is one of 
exclusion. Pyelonephritis, vascular anasto- 
motic failure, and ureteral obstruction are 
first ruled out. The last possibility is a 
particularly important one since 4 of the 
33 patients who lived for 4 months or 
longer have been shown to have partial 
ureteral obstruction which required secon- 
dary repair. In one case, there was strong 
evidence that the stricture resulted from 
healing of an earlier ureteral rejection. 
If diagnosed promptly, late homograft 
rejection can be reversed. The crucial step 
in the treatment of rejection is the resump- 
tion or increase of steroid dosage. In ad- 
dition, local irradiation to the graft and 
intravenous actinomycin C are both of use 
as emergency therapy. 
The chronic administration of azathio- 
prine has thus far appeared to be very well- 
tolerated by those patients who are receiv- 
ing only this drug, although its ultimate 
toxicity will take years to determine. The 
superimposition of steroid therapy, in those 
patients whose homograft function cannot 
be otherwise maintained, adds a serious 
risk. Gastrointestinal hemorrhages, infec- 
tions, aseptic bone necrosis, potentiation 
of hypertension, and severe obesity have all 
been observed. 
The course of five patients who received 
preliminary thymectomy and who survived 
more than 4 months is compared to that 
of the other recipients who did not receive 
this additional operation. One of the pa- 
tients who had thymic excision died after 
207 days of nonrenal complications. The 
other four had steroids discontinued in 9 
months or less, and none have had any 
evidence of delayed rejection 14 to 18 
months after operation. The 6 examples 
of late rejection all occurred in the other 
28 long-surviving patients who did not have 
removal of the thymus gland. The possible 
role of thymectomy in influencing these 
late events remains to be determined. 
Renal function ranged from adequate to 
essentially normal levels in all patients who 
survived longer than 4 months, except the 
one who died of uncontrolled late rejec- 
tion. In  four cases, in which late renal 
function was tested at a time when rejec- 
tion was not present, the results in paired 
donors and recipients were almost identical, 
suggesting hypertrophy in the homograft 
as well as in the donor's residual kidney. 
These results indicate that considerably 
more than half the patients who are treated 
with renal homotransplantation can be 
brought into a chronic stage, even when 
the statistics are unfavorably altered by the 
use of a substantial number of nonrelated 
donors as was the case in the present series. 
The data also indicate that overoptimism 
must be avoided in assessing the future role 
of this form of therapy since it is quite 
evident that many adverse factors still exist 
in the residual group of living patients, 
and that life-threatening late complications 
are going to be common. These include 
toxicity from drugs, especially if indefinite 
steroid therapy is required; late rejection; 
urologic complications; and subtle sub- 
clinical progression of pathologic altera- 
tions in the homograft. 
SUMMARIO IN INTERLINGUA 
Cinquanta-un patientes esseva tractate con 
homograffos renal ab donatores voluntari. Le 
plus recente del operationes esseva effectuate 
4 menses retro. Trenta superviventes es acces- 
sibile pro observationes catamnestic de un dura- 
tion de inter 4 e 186 menses. Le melior resul- 
tatos esseva obtenite in le uso de geneticamente 
relationate donatores. Tres patientes, altere 
que le 30 mentionate, superviveva 4 menses o 
pIus. 
Un numero de importante complicationes 
tardive esseva observate. Sex patientes mani- 
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datos trovate i n  le litteratura. L e  anormalitates 8. WOODRUFF, M. F. A.. ROBSON, J. S., NOLAN, 
characteristic de multe homograffos pare con- LAMBIEK, WILSON, T. I., CLARK, J. G.: Homo 
sister de  fibrosis interstitial, de  destruction de  transplantation of the kidney. Lancet 2: 675, 
capillares peritubular, e de  atrophia tubular, 1963. 
augmentate per  u n  spectro de  necrotic e 9. STARZL, T. E., MARCHIORO. T L., WADDELL, W. R.: The reversal of rejection in human renal proliferative lesiones afficiente arterias de  varie homografts with subsequent development of 
dimensiones. homograft tolerance. Surg. Gynec. Obstet. 
Complicationes altere que' rejection pote 117: 385. 1963. 
devenir hasardose pro le  patiente longemente 10. GOODWIN, W. E.. KAUFMAN, J. J., MIMS, M. M., 
post le homotransplantation. Obstruction ure- TURNER, R. D., GLASSOCK, R., GOLDMAN. R.. 
teral ha essite incontrate e conigite chirur- MAXWELL, N. M.: Human renal transplanta- 
gicamente in 4 patientes, e in  u n  de istes le tion. I. Clinical experience with 6 cases of 
constrictura ureteral pareva esser un  conse- renal homotransplantation. J. Urol. 89: 13, 
,,PO 1303. quentia tardive d e  u n  process0 d e  rejection. 11. KOSS, R. LEGRAIN, M., GAMEY, M. D~SARMENINE, Altere invalidante o potentialmente mortal J., MATH$. G., NEDEY, R., VOURC'H, C.: Homo- 
complicationes tardive esseva observate i n  pa- transplantation rknale chez l'homme. Mem. 
tientes requirente chronic therapia steroidee. Acad. Chir. (Paris) 87: 183, 1961. 
\ r 
Istos inc1;deva hemorrhagia gastrointestinal, 12. CALNE, R. Y., ALEXANDRE, G: P. J.. MURRAY, 
aseptic necrosis ossee, hypertension perdurative, J. E.: A Study of the effects of drugs in pro- 
e grados sever de  obesitate. b longing survival of homologous renal trans- 
Rejection tardive o morbiditate tardive es- plants .,.A,. in dogs. Ann. NY Acad. Sci. 99: 743, 
seva -frappantemente absente in  4 patientes 
qu i  habeva experientiate thymectomia pre- 
liminari e qui  attingeva le stadio chronic de  
convalescentia. Nulle d e  iste patientes recipe 
steroides, e nulle ha  monstrate evidentia d e  u n  
rejection tardive. Es discutite le  desiderato de  
u n  evalutation plus extense del rolo possibile 
de  thymectomia como factor d e  influentia 
favorabile super le tardive curso clinic post 
homotransplantation. 
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